Introduction
In carriers of hepatitis B surface antigen (HBsAg) viral replication may be continuing in the hepatocytes, with release of infectious virus into the blood stream, or may have stopped, with subsequent clearance of virus from the circulation. Hepatitis B virions may be detected in samples of serum or plasma by assaying for endogenous deoxyribonucleic acid (DNA) polymerase,1 2 although a more direct assay, based on the hybridisation of a cloned hepatitis B virus DNA probe to extracts of such samples, has become the method of choice because of its greater sensitivity and ease of application.5
The serological presence of hepatitis B e antigen (HBeAg) is correlated with that of infectious virus,6 7 and clearance of virus from the circulation often results in seroconversion with the appearance of antibodies to HBeAg (anti-HBe). hybridisation signal that could be detected on a two week, but not on a three day, autoradiographic exposure. All five serum samples that were negative for HBeAg and positive for hepatitis B virus DNA fell into this group.
Discussion
HBeAg was detected in 42 of 214 (20%) blood donors positive for HBsAg. This finding closely agrees with that of Dow et al, who found that 18 3%' of Scottish blood donors positive for HBsAg were also positive for HBeAg. 1 2Our detection of hepatitis B virus DNA in five serum samples that were negative for HBeAg, as well as in all but two of the samples positive for HBeAg, suggests that in this population one fifth of carriers of HBsAg who are otherwise apparently healthy have infectious virus in their circulation.
Our findings showed a good correlation between HBeAg and anti-HBe state and the presence of infectious virus as detected by DNA:DNA hybridisation in the population of the United Kingdom. This contrasts with findings in southern Europe9 10 and Israel,"1 where up to half of patients with HBeAb and liver disease may have detectable levels of hepatitis B virus DNA in their serum. Of the five donors who were negative for HBeAg and positive for hepatitis B virus DNA, one was born in India, one was Chinese, and the remaining three were British.
The detection of hepatitis B virus DNA in five serum samples that were negative for HBeAg, with the implication of the presence of infectious virus, has important consequences in the assessment of risk-for example, in pregnant women who are carriers. We therefore believe that analysis of serum samples for hepatitis B virus DNA by hybridisation should be the method of choice for determining whether a carrier of HBsAg is infectious. 
